Omeprazole and Ranitidine in Duodenal Ulcer Healing: Analysis of Comparative Clinical Trials

References

• Clissold S P, Campoli-Richards DM. Omeprazole, a preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome. Drugs 1986; 32: 15–47
   PubMed Web of Science ®Google Scholar
• Tytgat G NJ, Lamers C BHW, Hameeteman W, Jansen J MBJ, Wilson JA. Omeprazole in peptic ulcer resistant to histamine H2-receptor antagonist. Aliment Pharmacol Ther 1987; 1: 31–38
   PubMedGoogle Scholar
• Archambault A P, Pare P, Bailey R J, et al. Omeprazole (20 mg daily) versus cimetidine (1200mg daily) in duodenal ulcer healing and pain relief. Gastroenterology 1988; 94: 1130–1134
   PubMedGoogle Scholar
• Vantrappen G, Rutgeerts L, Schurmans P, Coene-Grachts JL. Omeprazole (40 mg) is superior to ranitidine in short-term treatment of ulcerative reflux oesophagitis. Dig Dis Sci 1988; 33: 523–529
   PubMed Web of Science ®Google Scholar
• Hetzel D J, Dent J, Reed W D, et al. Healing and relapse of severe peptic oesophagitis after treatment with omeprazole. Gastroenterology 1988; 95: 903–912
   PubMed Web of Science ®Google Scholar
• Klinkenberg-Knol E C, Jansen J MBJ, Festen H PM, Meuwissen S GM, Lamers C BHW. Double-blind multicentre comparison of omeprazole and ranitidine in the treatment of reflux oesophagitis. Lancet 1987; 1: 349–351
   PubMed Web of Science ®Google Scholar
• Lloyd-Davies K A, Rutgersson K, Solvell L. Omeprazole in the treatment of Zollinger-Ellison syndrome: a 4-year international study. Aliment Pharmacol Ther 1988; 2: 13–32
   PubMedGoogle Scholar
• Brunner G, Creutzfeldt W, Harke U, Lamberts R. Therapy with omeprazole in patients with peptic ulcerations resistant to extended high-dose ranitidine treatment. Digestion 1988; 39: 80–90
   PubMed Web of Science ®Google Scholar
• Boyd E JS, Wilson J A, Womsley KG. A double-blind comparison of continuous ranitidine with placebo after one year's successful maintenance of duodenal ulcer healing with ranitidine 150mg nocte. Gastroenterology 1983; 84: 1113
   Google Scholar
• Ireland A, Colin-Jones D G, Gear P, et al. Ranitidine 150 mg twice daily versus 300 mg nightly in treatment of duodenal ulcers. Lancet 1982; 2: 274–276
   Google Scholar
• Misiewicz J J, Bradbury JE. Review of trials of maintenance for the prevention of duodenal ulcer recurrence. Ranitidine: therapeutic advances, JJ Misiewicz, JR Wood. Excerpta Medica, Amsterdam 1984; 43–88
   Google Scholar
• Silvis GE. US multicenter trial comparing ranitidine to cimetidine as maintenance therapy following healing of duodenal ulcers. J Clin Gastroenterol 1985; 7: 482–487
   PubMed Web of Science ®Google Scholar
• Jorde R, Burhol P G, Hansen T. Ranitidine 150mg at night in the prevention of gastric ulcer relapse. Gut 1987; 28: 460–463
   PubMed Web of Science ®Google Scholar
• Chelvam P, Goh K L, Leong Y P, et al. Omeprazole compared with ranitidine in the treatment of duodenal ulcer. J Gastroenterol Hepatol 1989; 2: 53–61
   Google Scholar
• McFarland R J, Bateson M C, Green J RB, et al. Omeprazole provides quicker symptom relief and duodenal ulcer healing than ranitidine. Gastroenterology 1990; 98: 278–283
   PubMed Web of Science ®Google Scholar
• Hui W M, Lam S K, Lau W Y, et al. Omeprazole and ranitidine in duodenal ulcer healing and subsequent relapse: a randomized double-blind study with weekly endoscopic assessment. J Gastroenterol Hepatol 1989; 2: 35–43
   Google Scholar
• Marks I N, Winter T A, Lucke W, et al. Omeprazole and ranitidine in duodenal ulcer healing. S Afr Med J 1988; 74: 54–56
   PubMedGoogle Scholar
• Classen M, Dammann H G, Domschke W, et al. Omeprazole versus ranitidine in the treatment of duodenal ulcer–a German multicentre trial. Dtsch Med Wochenschr 1985; 110: 210–215
   PubMed Web of Science ®Google Scholar
• Mulder C JJ, Tytgat G NJ, Cluysenaer O JJ, et al. Omeprazole (20mgom) versus ranitidine (150mg bd) in duodenal ulcer healing and pain relief. Aliment Pharmacol Ther 1989; 3: 445–451
   PubMed Web of Science ®Google Scholar
• Barbara L, Blasi A, Cheli R, et al. Omeprazole versus ranitidine in the short-term treatment of duodenal ulcer; an Italian multicentre study. Hepatogastroenterol 1987; 34: 299–232
   Google Scholar
• Bardhan K D, Bianchi Porro G, Bose K, et al. A comparison of two different doses of omeprazole versus ranitidine in treatment of duodenal ulcers. J Clin Gastroenterol 1986; 8: 408–413
   PubMed Web of Science ®Google Scholar
• Van Deventer G M, Cagliola A, Whipple J, et al. Duodenal ulcer healing with omeprazole: a multicentre double-blind, ranitidine controlled study [Abstract]. Gastroenterology 1988; 94: 476
   Web of Science ®Google Scholar
• Lind T, Haglund U, Heruqvist H. Swedish multicentre study group Omeprazole or ranitidine for two or four weeks in duodenal ulcer patients; effect on healing, symptoms, and ulcer recurrence during intermittent short-term treatment. Gut 1989; 30: A1488
   Web of Science ®Google Scholar
• Delchier JCI, Sal JP, Eriksson S., et al. Double-blind multicentre comparison of omeprazole 20 mg once daily versus ranitidine 150 mg twice daily in the treatment of cimetidine or ranitidine resistant duodenal ulcers. Gut 1989; 30: 1173–1178
   PubMedGoogle Scholar
• Fleiss JL. Statistical methods for rates and proportions.2nd ed. J. Wiley and Sons, New York 1981; 173–175
   Google Scholar
• Jones D B, Howden C W, Burget D W, Kerr G D, Hunt RH. Acid suppression in duodenal ulcer: a meta-analysis to define optimal dosing with antisecretory drug. Gut 1987; 28: 1120–1127
   PubMed Web of Science ®Google Scholar
• Schunack W. What are the differences between the H2-receptor antagonist?. Aliment Pharmacol Ther 1987; 1: 493S–503S
   Google Scholar
• Bertaccini G, Coruzzi G. Pharmacology of the treatment of peptic ulcer disease. Dig Dis Sci 1985; 30(43)S–51S
   Google Scholar
• Sölvell L. Clinical safety of omeprazole. Can J Gastroenterol 1989; 3(91)A–97A
   Google Scholar
• Burlinson B, Morriss SH. Genotoxicity studies of gastric acid inhibiting drugs. Lancet 1990; 335: 419
   PubMed Web of Science ®Google Scholar
• Ekman L, Boksfoldi G. Genotoxicity. Lancet 1990; 1: 419–420
   Google Scholar
• William Green F, Kaplan M M, Curtis L E, Levine PM. Effect of acid and pepsin on blood coagulation and platelet aggregation. Gastroenterology 1978; 74: 38–43
   PubMedGoogle Scholar